Real-time enrollment status for this hypogammaglobulinemia clinical trial
Current Status
Recruiting
Checked: September 3, 2026 at 1:46 AM UTC
| NCT Number | NCT07220915 |
| Recruiting Status | Recruiting |
| Condition | Hypogammaglobulinemia |
| Phase | PHASE3 |
| Target Enrollment | 360 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Octapharma |
| Last Updated on CT.gov | August 12, 2026 (3 weeks ago) |
As of September 3, 2026: Clinical trial NCT07220915 is currently recruiting participants. This phase3 study for hypogammaglobulinemia is actively seeking new participants at 1 location across the United States. The study is sponsored by Octapharma. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07220915 is actively recruiting participants as of September 3, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07220915 was last updated 3 weeks ago (August 12, 2026). HelloStudys verifies this status automatically.